Dentsply SironaXRAY +3.03%51 Receivables Turnover is 1.34 as of Mar. 2026. GuruFocus rates XRAY with a GF Score™ of 51/100 and a GF Value™ of $19.03 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 811 Medical Devices & Instruments companies, Dentsply Sirona ranks better than 52.4% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Dentsply Sirona's Revenue for the
three
months ended in Mar. 2026 was $880 Mil. Dentsply Sirona's average Accounts Receivable for the
three
months ended in Mar. 2026 was $655 Mil.
Hence, Dentsply Sirona's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.34.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Dentsply Sirona Receivables Turnover Related Terms
Dentsply Sirona Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Dentsply Sirona's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XRAY vs LMAT, PLSE, KMTS: Receivables Turnover Comparison
For the Medical Instruments & Supplies subindustry, Dentsply Sirona's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dentsply Sirona Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dentsply Sirona's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Dentsply Sirona's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dentsply Sirona (XRAY) has a Receivables Turnover of 1.34 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dentsply Sirona and its competitors. According to the industry distribution chart, Dentsply Sirona ranks #386 out of 811 companies in the Medical Devices & Instruments industry, placing it in the top 47.6%.
Is Dentsply Sirona's Receivables Turnover too high?
Dentsply Sirona's current Receivables Turnover is 1.34. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Dentsply Sirona's value of 1.34 is 75.7% below this industry median. Based on the distribution chart, Dentsply Sirona ranks #386 out of 811 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dentsply Sirona has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Receivables Turnover compare to LMAT and PLSE?
According to the Medical Devices & Instruments industry distribution chart, Dentsply Sirona ranks #386 out of 811 companies for Receivables Turnover. This puts Dentsply Sirona in the upper half of its industry. The industry median Receivables Turnover is 5.51. Dentsply Sirona's value of 1.34 is 75.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dentsply Sirona's current Receivables Turnover of 1.34 is 75.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Dentsply Sirona and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dentsply Sirona's current Receivables Turnover is 1.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.03, compared to a current price of $12.26 — trading 35.6% below its estimated fair value. The current Receivables Turnover is 1.34 and 75.7% below the Medical Devices & Instruments industry median of 5.51. Dentsply Sirona's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Receivables Turnover is 1.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dentsply Sirona (XRAY) Overvalued in 2026?
Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued.
The current stock price of $12.26 is trading 35.6% below its estimated GF Value™ of $19.03.
GuruFocus considers Dentsply Sirona to be Possible Value Trap.
Key valuation signals for XRAY:
Receivables Turnover: 1.34
GF Value™: $19.03 vs. price of $12.26 (35.6% below fair value)
Industry Position: 75.7% below the Medical Devices & Instruments median (#386 of 811)
No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
51GF Score
Get the complete analysis for XRAY
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XRAY has been successfully added to your 
